Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma

Testing of the MGMT promoter methylation status in glioblastoma is relevant for clinical decision making and research applications. Two recent and independent phase III therapy trials confirmed a prognostic and predictive value of the MGMT promoter methylation status in elderly glioblastoma patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Preusser, Matthias, Berghoff, Anna S., Manzl, Claudia, Filipits, Martin, Weinhäusel, Andreas, Pulverer, Walter, Dieckmann, Karin, Widhalm, Georg, Wöhrer, Adelheid, Knosp, Engelbert, Marosi, Christine, Hainfellner, Johannes A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Dustri-Verlag Dr. Karl Feistle 2014
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3891253/
https://ncbi.nlm.nih.gov/pubmed/24359605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/NP300730
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky